Cargando…
Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2
Since the time of its appearance until present, COVID-19 has spread worldwide, with over 71 million confirmed cases and over 1.6 million deaths reported by the World Health Organization (WHO). In addition to the fact that cases of COVID-19 are increasing worldwide, the Delta and Omicron variants hav...
Autores principales: | Petrou, Anthi, Zagaliotis, Panagiotis, Theodoroula, Nikoleta F., Mystridis, George A., Vizirianakis, Ioannis S., Walsh, Thomas J., Geronikaki, Athina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000570/ https://www.ncbi.nlm.nih.gov/pubmed/35408577 http://dx.doi.org/10.3390/molecules27072180 |
Ejemplares similares
-
Thiazolidin-4-Ones as Potential Antimicrobial Agents: Experimental and In Silico Evaluation
por: Tratrat, Christophe, et al.
Publicado: (2022) -
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling
por: Zagaliotis, Panagiotis, et al.
Publicado: (2022) -
Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
por: Petrou, Anthi, et al.
Publicado: (2019) -
Thiazole Ring—A Biologically Active Scaffold
por: Petrou, Anthi, et al.
Publicado: (2021) -
4-(Indol-3-yl)thiazole-2-amines and 4-ιndol-3-yl)thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis, In Silico and In Vitro Evaluation
por: Simakov, Sergei, et al.
Publicado: (2021)